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THE severe losses during 1960 of young turkeys and ducks resulting from
"Turkey X disease ", were eventually traced to the feeding of a diet containing
a proportion of groundnuts (Arachis hypogea L.) which had become contaminated
with strains of the common fungus Aspergillusflavus (for a review see Spensley,
1963). Hepatic necrosis associated with generalized bile duct proliferation
was a common finding in the birds, and although the effects resembled those of
Senecio alkaloid poisoning, no known alkaloid or insecticide could be implicated.
At this stage the groundnut meal was administered to rats in their diet by
workers at the Unilever Research Laboratory, at Bedford (Lancaster, Jenkins
and Philp, 1961). The acute effects seen in birds were lacking, but continued
feeding produced severe liver lesions ; after 30 weeks all livers were grossly
abnormal and 9 out of 11 rats developed multiple liver tumours including car-
cinomas, two rats having lung metastases.
In the meantime concentration and purification of the active toxic material
proceeded at the Tropical Products Institute and the Central Veterinary Labora-
tory (Sargeant, Sheridan, O'Kelly and Carnaghan, 1961; Nesbitt, O'Kelly,
Sargeant and Sheridan, 1962) and at the Unilever Research Laboratories (De
Iongh, Beerthuis, Vles, Barrett and Ord, 1962). Two major and two or more
minor toxic components were present-they were named Aflatoxins, after the
mould, and distinguished on the basis of their blue or green fluorescence as
aflatoxins B or G respectively, the main components of the crystalline toxin
being named B1 and G1 (van der Zijden et al., 1962; Nesbitt et al., 1962; Asao
et al., 1963).
Aflatoxin B1, C17H1206, has the highest toxicity (LD50 for 51 g. day-old
ducklings, 28 jag.; aflatoxin G1, LD50 90 ,ug. according to Asao et al. (1963)).
Aflatoxin G1 has one extra oxygen atom in the molecule (C17H1207). It was
early recognized that both substances contain the lactone grouping and asso-
ciated ac,#-unsaturated bonds. Finally (Asao et al., 1963) the following formulae
were arrived at:
Aflatoxin B
I
Aflatoxin G
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A variant on these two formulae in which the extreme right-hand rings are
inverted, but the remaining structure is unaltered, has recently been proposed
by van der Merwe, Fourie and Scott (1963). In either case, aflatoxin B1 contains
an o4,8-unsaturated 8-lactone and a cyclopentenone ring in which the two carbonyl
groups are cross-conjugated with the double bonds, while aflatoxin G1, with its
additional oxygen atom, has two cross-conjugated a4l-unsaturated 6-lactonic
rings.
In previous papers (Dickens and Jones, 1961, 1963; Dickens, 1962, 1964)
we have studied the effects on the rat of administration of a group of unsaturated
lactones and have found that a number of y- and &-lactones in the chemical
structure of which the carbonyl function is conjugated with one or more double
bonds, are carcinogenic. In all cases tested, prolonged administration proved
necessary for carcinogenesis, but with this provision a high proportion of rats
developed local tumours at the subcutaneous injection site with reasonably
small doses (0.1-2 mg.) of the more highly carcinogenic lactones in this series.
The tumours were malignant as judged histologically and by growth on trans-
plantation into other rats, being mainly sarcomas or fibrosarcomas. Few distant
tumours were seen in this series.
Since the aflatoxins contain a similar type of unsaturated lactone structure
to that present in our series of carcinogenic lactones, we thought it desirable to
test purified aflatoxin for carcinogenic ability by means of its subcutaneous in-
jection into rats.
This was particularly important, because the evidence available hitherto that
aflatoxin is carcinogenic, though reasonably strong, is presumptive; being based
on the production of liver tumours after feeding whole infected groundnut meal,
as shown by Lancaster et al. (1961). Although the diet used may safely be judged
to have contained aflatoxin (Sargeant et al., 1961), and was highly toxic to young
turkeys, the actual proof that the carcinogenic action was due to aflatoxin itself
and not to some other contaminant demands the demonstration that purified
aflatoxin preparations are also carcinogenic.
Through the kindness of the workers at the Tropical Products Institute,
London, in supplying us with a crystalline sample of mixed aflatoxins, we have
now been able to fill this gap in the evidence. In experiments during the past
two years, we found that a preparation consisting almost entirely of aflatoxins
B1 and G1 was actively carcinogenic on repeated subcutaneous injection into rats.
EXPERIMENTAL
The details of animal experiments, injection and histological techniques were
as given by Dickens and Jones (1961, 1963), except where stated below.
Material8
A preparation of mixed aflatoxin was generously supplied in March 1962 by
Dr. B. F. Nesbitt and Dr. K. Sargeant of the Tropical Products Institute through
the kindness of Mr. E. S. Hiscocks, Director. At that time the full structure of
the compounds had not been worked out. The crystalline material supplied was
obtained from cultures of a toxin-producing strain of Asperqillu8 flavus, Link ex
Fries, originally isolated as one of eight fungal species present in a highly toxic
batch of groundnuts (Sargeant et al., 1961). Although either sterile groundnuts
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or suitable artificial media are available for toxin productioni in culture, the
material used here was obtained by growth on an artificial medium (cf. De longh
et al., 1962). (A further larger quantity of aflatoxin from cultures grown on
groundnuts has since been made available to us through Dr. B. D. Lush of the
Medical Research Council but the tests on this are still in progress. The compo-
sition of this material is closely similar.)
The crystalline toxin used here consisted almost entirely of aflatoxins B and G,
the analysis (for which we are indebted to Dr. L. Horton, Tropical Products
Institute) showed: aflatoxin B1, 37'7 ± 2-3 per cent; aflatoxin G1, 56-4 ± 2-7
per cent. Aflatoxins B2 and G. were present, but they were clearly very
minor components. The material is photosensitive and was therefore stored
in the dark at +4° C.
For injection into rats, doses in arachis oil in two strengths were prepared
containing respectively 50 Itg. and 500 jag. per 0.5 ml. : the former dissolved
completely, whilst the latter dose was partly present as a fine suspension.
The arachis oil (B.P.) used in these experiments was a large batch kept specially
for the purpose and was the same material as that used in our previous experi-
ments. Repeated injections of 0 5 ml. subcutaneously into rats of this oil alone
over long periods gave no incidence oflocal tumours in 18 rats previously observed
(Dickens and Jones, 1961, 1963). A smaller group of 6 rats given oil alone in
the present series also developed no tumours.
Anini al experime8ts
Male rats, weighing about 100 g., were injected twice weekly with aflatoxin
dissolved in arachis oil. All the injections were of 0 5 ml., delivered into a single
subcutaneous site on the right flank of each animal. One group of 6 rats (A)
reeeived 50 ,Ig. aflatoxin at each injection and was treated for a period of at least
50 weeks, while the other group of 6 rats (B) received 500 ,tg. aflatoxin at each
injection for a period of only 8 weeks, when injections ceased and the animals
in this group were kept under observation for a total period of 30 weeks.
The animals were examined at least twice a week for tumours developing at
the site of the injections, and suspected lumps were confirmed to be tumours
by histological examination and their ability to grow when transplanted sub-
eutaneously into young female rats.
Rats which bore tumours at the site of injection were searched for tumours
in other sites and the livers of some were examined histologically even thougl
they appeared normal on macroscopic examination.
RESULTS
Tumours developed in each of the 6 rats given continuous twiee-weekly in-
jections of 50 ,tg. of aflatoxin, and in each of the 5 rats which survived sixteen
injections of 500 pg. of aflatoxin (Table I). These tumours grew rapidly and
were usually large enough to be transplanted within a week or two of the time
w,hen they were first detected. All the tumours were typically sarcomas or
fibrosarcomas (Fig. 1 and 2), though they varied greatly in their proliferative
activity, their ability to grow on transplantation (Table II), and their " wildness "
as judged by the presence of giant cells and multinucleate cells in the tumour.
Tumours were not found in any ofthese animals except at the site ofthe injections,
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TABLE I.-Carcinogenicity of Afiatoxin administered Twice Weekly by
Subcutlaneots Injection to Male Rats
Earliest Number of
Duration of AIm1ount at appearance rats alive Number of Total period
administrationi each injection of tumours when first rats developinig observed
(weeks) (pg.) (weeks) tumour seen tumours (weeks)
Gro?tp A
60 50 21 6 6 60
Grotup B
8 500 20 5 5 30
TABLE II.-Characteristics of Tumours Produced in Male Rats by
Subcutaneous Injection ofAflatoxin
Development Weight of Takes of
time Total dose tumour Histology of transplants
(weeks) (mg.) (g.-* tumour in rats
Group A (50 lig. doses throughout)
21 . 2-1 . 22 Fibrosarcoma 4/6
22' . 2-3 . 18 . Fibrosarcoma 3/6
30 . 3-0 27 . Fibrosarcoma 0/6
33 . 3-3 12 Fibrosarcoma 6/6
33 3-3 28 . Sarcoma . N.A.
60 . . 60 28 . Sarcoma . 0/6
Group B: (500 jeg. doses for 8 weeks only)
20 . . 80 39 . Fibrosarcoma 1/6
24 . . 8-0 . 51 . Sarcoma 2/6
24 . . 8-0 . 46 . Fibrosarcoma 6/6
30 . . 8-0 . 23 . Fibrosarcoma . 2/6
30 . 80 . t . Fibrosarcoma . N.A.
* When animal killed, usually 1-2 weeks after detection of tumour.
N.A. = not attempted. t Biopsy Specimen.
though one rat in group A which had received 50 ,tg. of aflatoxin twice weekly
for 34 weeks had a grossly enlarged lymph node mass at the junction of the large
intestine with the colon. Histologically, these nodes were severely hyperplastic
and haemorrhagic, but no indications of neoplastic or malignant changes were
seen.
The livers of the rats which had received 16 injections of 500 ,tg. of aflatoxini
have been examined microscopically; four of these were remarkably normal
considering the high dose given, while the other from a rat killed 18 weeks after
the last injection was obviously affected (Fig. 3) and showed a number of fat-
EXPLANATION OF PLATE
FIG. 1. Fibrosarcoma from the injection site of a male rat treated with 50 ,ug. aflatoxin in oil
twice a week for 33 weeks. This tumour grew in 6 rats as a transplant. x 400.
FIG. 2.-Sarcoma from the injection site of a male rat treated with 500 l4g. aflatoxin in oil
twice a week for 8 weeks. The tumour first appeared 16 weeks after the last injection
and was filled with fluid. An extensive system of vessels is shown within the substance
of the tumour. This tumour grew in 2 of 6 rats as a transplant. x 250.
FIG. 3.-Lobule of the liver of a male rat treated with 500 jig. aflatoxin in oil twice a week
for 8 weeks. This rat was killed when a local tumour developed 12 weeks after the last
injection. Necrosis of the parenchyma is seen to be severe and there is separation of the
normal parenchymal cell cords. x 100.BRITISHi JOURNAL OF CANCER.
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laden cells at the periphery of the lobules, together with hyaline necrosis in
patches which had a centrilobular distribution. There was no evidence of re-
generation of the parenchyma in this liver. In rats which had received the
smaller dose of aflatoxin the livers were free of serious pathological lesions, but
showed a small amount of perivenular infiltration with round cells and some
variation in the size of the liver cell nuclei suggesting recent regeneration of liver
parenchyma.
A group of 20 mice, together with 20 oil-treated controls, is at present receiving
10 ltg. doses of aflatoxin in 01 ml. of arachis oil twice weekly by subcutaneous
injection, but the experiment has continued for only 12 weeks and no tumours
have yet arisen.
DISCUSSION
Aspergillus flavus is a commoin mould which can be isolated from many food-
stuffs especially when these have been stored in moist hot climatic conditions,
and it is present in tropical soils. Fortunately not all strains of this organism
produce aflatoxin, although some may produce other, possibly related, toxins
(Spensley, 1963), and this aspect needs further study. A valuable step forward
is the chemical method of detection and assay of aflatoxin devised by the Tropical
Products Institute workers (Tropical Products Institute, 1962), which can be
used to test foodstuffs which have been contaminated with toxin-producing strains
of the mould.
Refined groundnut oil (arachis or peanut oil) is stated to be always toxin-free,
presumably because of the alkali-wash process used in its preparation (Spensley,
1963). This is most fortunate, as the oil is extensively used for foodstuff pre-
paration. Since we have used arachis oil as a solvent in most of our experiments
on carcinogenesis by lactones, we have carried out prolonged tests with repeated
subcutaneous injections of the oil alone in total amounts up to 61 ml. per rat
over periods up to 61 weeks, with the result that survivors observed for up to
106 weeks after the start of the injections were free from tumour (Dickens and
Jones, 1961, 1963). We have previously commented (Dickens and Jones, 1961)
on the fact that Walpole, Roberts, Rose, Hendry and Homer (1954) observed a
low incidence oftumours in their rats injected only with previously heated arachis
oil, and we suggested that their heat-sterilization process might perhaps have
accounted for this difference. An alternative explanation, which now needs to
be considered and if possible ruled out by direct experimental evidence, might be
that their particular sample ofoil may have happened to contain very low amounts
of aflatoxin. This substance withstands quite high temperatures.
The acute toxicity of aflatoxin primarily affects the liver and bile duct epi-
thelium and varies greatly with the species of animal. Ducklings and young
turkeys are extremely susceptible, while chickens are comparatively resistant.
Young pigs and calves are susceptible but lambs much less so (Spensley, 1963;
Alleroft and Carnaghan, 1963). The rat is evidently also a resistant species both
to acute toxicity and, as our experiments show, to a prolonged course of in-
jections, as far as liver damage and injury to health, other than the production
of local tumours, is concerned. Repeated subcutaneous doses of 500 ,tg. (about
5 mg./kg. body weight) in our rats up to a total dose in 8 weeks of 8 mg. (80 mg./
kg.) had surprisingly little effect other than the carcinogenesis which developed
after 20 weeks. In the duckling, the LD50 based on a single oral administration
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amounts to 0-56 mg./kg. for aflatoxin B and 1P8 mg. for aflatoxin G (Asao et al.,
1963), but very few tests based upon injection of the purified material appear to
have been reported. The effects of feeding infected groundnut meal to the
rat have already been mentioned (Lancaster et al., 1961 ; see also Schoenthal,
1961).
In our two series, A and B, of experiments in which purified aflatoxin was
injected into rats there was little difference in the incidence or time offirst appear-
ance (20-21 weeks) of tumours in the two groups, in spite of the fact that ten
times the amount of aflatoxin per dose was given to series B, but this dosage
was terminated after twice-weekly injections had continued for only 8 weeks.
In series A with a similar carcinogenic effect, doses of only 50 ,ug. continued twice
weekly throughout the period of the experiment were equally effective.
This is the lowest carcinogenically active dosage that we have observed in
this series of studies of carcinogenic lactones, and suggests that aflatoxin is a
highly potent carcinogen for connective tissues of the rat. Moreover, since all
the treated animals developed tumours, it is possible that still lower doses might
prove effective in future experiments. It also appears likely that an important
feature is the constant exposure of the affected tissue to the carcinogen, and that
even more frequent prolonged dosage might prove particularly effective with very
small doses of substances such as lactones which are alkali-labile and therefore
likely to be dispersed quite rapidly in the form of salts orother reaction products
from the injection site. This question is important in considering the possibility
of carcinogens arising in the course of metabolism, perhaps as a result of some
defect of cell metabolism.
The present experiments appear to be the first tests of carcinogenesis in which
a purified preparation of aflatoxin has been administered, rather than an infected
foodstuff. As such, they show clearly that aflatoxin itself is a carcinogen, and
that it is capable of inducing sarcoma formation at the site of injection. More-
over, it is highly active in thisrespect at the lowestdosage tested (50 ,ug./injection),
with an induction time of only 20-21 weeks. It is therefore probable that afla-
toxin was in fact the active agent in earlier experiments showing the production
of liver carcinoma by feeding groundnuts infected with A.flavus (Lancaster et al.,
1961; Schoenthal, 1961).
The aflatoxin used in the present experiments consisted almost entirely
(94 per cent) of aflatoxins B1 and G1, in a ratio of approximately 2: 3. These
two components are now available separately and tests are in progress to compare
their relative carcinogenic activities.
Whether aflatoxin Bi or G1, or both, prove to be carcinogenic, these substances
have the chemical structure of the a,f-unsaturated lactone ring, with further
conjugation within the molecule, which we have consistently found associated
with carcinogenesis in our 5- and 6-membered lactone series (Dickens and Jones,
1961, 1963). Aflatoxin G1 in fact, possesses two such unsaturated, mutually
conjugated, lactone rings; while aflatoxin B1 has one such lactone ring conjugated
with the carbonyl group in the cyclopentenonering (cf. part-formulae III and IV):
In the series of carcinogenic compounds studied by Dickens and Jones (1961,
1963) a simpler type of double conjugation is present in the lactones patulin (V),
methyl protoanemonin (VI) and maleic anhydride (VII). Single conjugation
of a double bond with the lactonic carbonyl group is present in penicillic acid
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(VIII), parasorbic acid (IX) and 2-hexenoic-y-lactone (X), all of which we found
to be active carcinogens also.
In experiments as yet incomplete, the next lower homologue of (X), namely
/3-angelica lactone, and the antibiotic and tumour-inhibitory substance sarko-
mycin (XI; as the sodium salt) are producing tumours in the injected rats
(Dickens and Jones, unpublished observations). The presence of the carbonyl
group conjugated with the double bond is again a common feature in the chemical
structure of all this series of carcinogenic compounds, which is now shown to
include as a highly active member the mould product aflatoxin.
SUMMARY
1. Tests for carcinogenic activity, after the repeated subcutaneous injection
into rats, have been made upon aflatoxin, the toxic product formed by the mould
Aspergillus flavu,s, a commonly occurring contaminant of groundnuts and other
foodstuffs.
2. A crystalline preparation consisting of 38 per cent aflatoxin B and 56 per
cent aflatoxin G was used: doses of 50 ,ug. and 500 ,tg./0.5 ml. arachis oil were
injected twice weekly into rats. The control rats given oil alone have produced
no tumours.
3. There was little difference between the tumour incidence or lag-period
(20-21 weeks) whether 50 ,ug. doses were continued for many weeks or 500 ,ug.
doses were discontinued after only 8 weeks. All 6 animals in the former series,
and the 5 survivors in the latter series, bore tumours at the injection site.
4. The tumours proved to be sarcomas or fibrosarcomas and some were success-
fully transplanted to other rats.
5. These results establish that the purified aflatoxin is an active carcinogen
for the subcutaneous tissues of the rat.
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